Public Health Foundation of India, Indian Institute of Public Health - Hyderabad, India.
Tuberculosis (Edinb). 2012 Jul;92(4):301-6. doi: 10.1016/j.tube.2012.02.009. Epub 2012 Apr 14.
W.H.O. defines Totally Drug-Resistant Tuberculosis (TDR-TB) as Tuberculosis caused due to a virulent strain of tuberculosis that seems to be resistant to all known treatments. In a recent correspondence, Zarir F. Udwadia and others described what they termed as "first patients from India with TDR tuberculosis". The processes and weakness ingrained in the vastness of Indian society and health system leading to drug resistance reveal multitude layers of weakness. This review aims at listing some of the important factors and levels responsible for the development of resistance in TB. The review identifies access issues, poor adherence to short-course chemotherapy, poor knowledge, practices and quality TB drugs in the private sector, resistance against some of second-line drugs prevalent in India and poor utilization of diagnostic services as the factors for causing TB resistance in India.
世界卫生组织将完全耐药结核病(TDR-TB)定义为由一种似乎对所有已知治疗方法都具有耐药性的烈性结核菌株引起的结核病。在最近的一封通信中,Zarir F. Udwadia 等人描述了他们所谓的“印度首批耐多药结核病患者”。导致耐药性的印度社会和卫生系统的巨大过程和弱点揭示了多层次的弱点。本综述旨在列出一些导致结核病耐药性发展的重要因素和层面。该综述确定了一些因素,包括获得治疗的机会问题、对短程化疗的依从性差、知识水平低、私营部门的结核病药物质量和实践差、对印度流行的一些二线药物的耐药性以及诊断服务利用不足,这些都是导致印度结核病耐药性的因素。